IMP
Process View
common partner smad protein phosphorylation
The process of introducing a phosphate group on to a common-partner SMAD protein. A common partner SMAD protein binds to pathway-restricted SMAD proteins forming a complex that translocates to the nucleus.
Loading network...
In addition to gene-name show these genes:
Click on a gene's description to view its network relationships with genes known to be involved in "common partner smad protein phosphorylation"
| Name | Description | Probability | Func Analog Organism | |
|---|---|---|---|---|
| SMAD3 | SMAD family member 3 | 1.000 | Human | |
| SMAD2 | SMAD family member 2 | 0.999 | ||
| SMURF2 | SMAD specific E3 ubiquitin protein ligase 2 | 0.995 | ||
| SMAD7 | SMAD family member 7 | 0.991 | Human | |
| TGFBR2 | transforming growth factor, beta receptor II (70/80kDa) | 0.989 | Rat | |
| BMPR1A | bone morphogenetic protein receptor, type IA | 0.986 | ||
| SMAD1 | SMAD family member 1 | 0.979 | Human | |
| FSTL1 | follistatin-like 1 | 0.944 | ||
| SPTAN1 | spectrin, alpha, non-erythrocytic 1 (alpha-fodrin) | 0.937 | ||
| TGFB1 | transforming growth factor, beta 1 | 0.831 | ||
| SMAD4 | SMAD family member 4 | 0.487 | Human | |
| SMAD5 | SMAD family member 5 | 0.483 | Human | |
| TGFBR1 | transforming growth factor, beta receptor 1 | 0.474 | ||
| HIPK2 | homeodomain interacting protein kinase 2 | 0.473 | ||
| TGFB3 | transforming growth factor, beta 3 | 0.320 | ||
| SMURF1 | SMAD specific E3 ubiquitin protein ligase 1 | 0.316 | ||
| SMAD6 | SMAD family member 6 | 0.260 | Human | |
| SKI | v-ski sarcoma viral oncogene homolog (avian) | 0.259 | ||
| ENG | endoglin | 0.230 | ||
| UBE2I | ubiquitin-conjugating enzyme E2I (UBC9 homolog, yeast) | 0.203 | ||
| RNF11 | ring finger protein 11 | 0.172 | ||
| TRAF4 | TNF receptor-associated factor 4 | 0.163 | ||
| DAB2 | disabled homolog 2, mitogen-responsive phosphoprotein (Drosophila) | 0.142 | ||
| ZFYVE9 | zinc finger, FYVE domain containing 9 | 0.123 | ||
| WFIKKN2 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 2 | 0.109 | ||
| CXXC5 | CXXC finger protein 5 | 0.106 | ||
| AXIN1 | axin 1 | 0.103 | ||
| DAXX | death-domain associated protein | 0.096 | ||
| SMAD9 | SMAD family member 9 | 0.087 | ||
| SPG20 | spastic paraplegia 20 (Troyer syndrome) | 0.081 | ||
| FBXL15 | F-box and leucine-rich repeat protein 15 | 0.072 | ||
| PIAS1 | protein inhibitor of activated STAT, 1 | 0.069 | ||
| FANCC | Fanconi anemia, complementation group C | 0.050 | ||
| MAPK7 | mitogen-activated protein kinase 7 | 0.047 | ||
| DIP2A | DIP2 disco-interacting protein 2 homolog A (Drosophila) | 0.038 | ||
| PIAS4 | protein inhibitor of activated STAT, 4 | 0.037 | ||
| NRP1 | neuropilin 1 | 0.036 | ||
| BMPR2 | bone morphogenetic protein receptor, type II (serine/threonine kinase) | 0.034 | ||
| BMP4 | bone morphogenetic protein 4 | 0.032 | ||
| BCL3 | B-cell CLL/lymphoma 3 | 0.032 | ||
| RELB | v-rel reticuloendotheliosis viral oncogene homolog B | 0.031 | ||
| DDX24 | DEAD (Asp-Glu-Ala-Asp) box polypeptide 24 | 0.030 | ||
| ZNF512B | zinc finger protein 512B | 0.028 | ||
| BMP2 | bone morphogenetic protein 2 | 0.028 | Human | |
| RASSF1 | Ras association (RalGDS/AF-6) domain family member 1 | 0.027 | ||
| SNCA | synuclein, alpha (non A4 component of amyloid precursor) | 0.026 | ||
| FAS | Fas (TNF receptor superfamily, member 6) | 0.026 | ||
| MKL2 | MKL/myocardin-like 2 | 0.022 | ||
| TFPI2 | tissue factor pathway inhibitor 2 | 0.022 | ||
| SKIL | SKI-like oncogene | 0.022 | ||
| PLEKHA5 | pleckstrin homology domain containing, family A member 5 | 0.021 | ||
| SOX7 | SRY (sex determining region Y)-box 7 | 0.020 | ||
| NEDD4 | neural precursor cell expressed, developmentally down-regulated 4 | 0.019 | ||
| ETS1 | v-ets erythroblastosis virus E26 oncogene homolog 1 (avian) | 0.018 | ||
| WFIKKN1 | WAP, follistatin/kazal, immunoglobulin, kunitz and netrin domain containing 1 | 0.018 | ||
| STAMBP | STAM binding protein | 0.017 | ||
| SREBF2 | sterol regulatory element binding transcription factor 2 | 0.017 | ||
| TNIK | TRAF2 and NCK interacting kinase | 0.017 | ||
| MEF2C | myocyte enhancer factor 2C | 0.016 | ||
| TGFBR3 | transforming growth factor, beta receptor III | 0.016 | ||
| NEDD9 | neural precursor cell expressed, developmentally down-regulated 9 | 0.016 | ||
| APP | amyloid beta (A4) precursor protein | 0.016 | ||
| RPS6KA5 | ribosomal protein S6 kinase, 90kDa, polypeptide 5 | 0.016 | ||
| BMPR1B | bone morphogenetic protein receptor, type IB | 0.015 | ||
| ID3 | inhibitor of DNA binding 3, dominant negative helix-loop-helix protein | 0.014 | ||
| ACVR2B | activin A receptor, type IIB | 0.014 | ||
| CDKN2A | cyclin-dependent kinase inhibitor 2A (melanoma, p16, inhibits CDK4) | 0.013 | ||
| THBS1 | thrombospondin 1 | 0.013 | ||
| ING2 | inhibitor of growth family, member 2 | 0.013 | ||
| HEYL | hairy/enhancer-of-split related with YRPW motif-like | 0.013 | ||
| YAP1 | Yes-associated protein 1 | 0.013 | ||
| DST | dystonin | 0.012 | ||
| VPS24 | vacuolar protein sorting 24 homolog (S. cerevisiae) | 0.012 | ||
| TGFB2 | transforming growth factor, beta 2 | 0.012 | Human | |
| HOXC8 | homeobox C8 | 0.012 | ||
| EVL | Enah/Vasp-like | 0.012 | ||
| PDGFRA | platelet-derived growth factor receptor, alpha polypeptide | 0.012 | ||
| ITGA5 | integrin, alpha 5 (fibronectin receptor, alpha polypeptide) | 0.010 | ||
| RNF111 | ring finger protein 111 | 0.010 | ||
| MAP2K5 | mitogen-activated protein kinase kinase 5 | 0.010 | ||
| ELK1 | ELK1, member of ETS oncogene family | 0.010 | ||
| PIAS2 | protein inhibitor of activated STAT, 2 | 0.010 |